Scarica l'app Stockscreener
12.16
1.45%
-0.155
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$12.32
Aprire:
$12.44
Volume 24 ore:
3.27M
Relative Volume:
0.63
Capitalizzazione di mercato:
$2.44B
Reddito:
$3.68B
Utile/perdita netta:
$-627.00M
Rapporto P/E:
-3.8647
EPS:
-3.1477
Flusso di cassa netto:
$104.00M
1 W Prestazione:
+14.43%
1M Prestazione:
+21.41%
6M Prestazione:
-1.85%
1 anno Prestazione:
-23.83%
Intervallo 1D:
$12.04
$12.44
Intervallo di 1 settimana:
$10.61
$12.48
Portata 52W:
$9.405
$16.96
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.18 | 2.47B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
428.19 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.26 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.84 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.88 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.80 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Sell |
| 2026-02-19 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
Dentsply Sirona: The Recovery Story Needs More Than A Stock Rebound - Seeking Alpha
Dentsply Sirona stock rating held at Neutral by Piper Sandler - Investing.com
DENTSPLY SIRONA Inc. (XRAY)’s Shares Are Flat Since Cramer Commented On Them - Yahoo Finance Singapore
From the first dental MRI to orthodontic AI: Four FDA clearances reshaping dentistry - Oral Health Group
Rebecca Whitney assumes CEO role at Young Innovations - DrBicuspid.com
XRAYDENTSPLY Sirona Inc Options - Finviz
DENTSPLY SIRONA (XRAY) On 5 Million CEREC Restorations And The Undervalued Stock Narrative - Sahm
PDS Health and Dentsply Sirona Surpass 5 Million CEREC Chairside Restorations - Quiver Quantitative
Millions of same-day dental restorations: PDS Health hits 5M - Stock Titan
Form 4 Dentsply Sirona Inc For: 1 July By Investing.com - Investing.com UK
[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity - Stock Titan
Guttacore Obturators Size #25Pack Of 30, Tulsa Dental / Dentsply (Free Shipping) - Santo André BIZ
Does Dentsply Sirona’s (XRAY) Index Shift Recast Its Role in Dental Innovation Leadership? - simplywall.st
Seller dominance drives Dentsply Sirona stock down to $10.54 in weak session - Traders Union
DENTSPLY SIRONA : PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry - marketscreener.com
Dentsply Sirona and HeyGears expand digital denture collaboration to one-piece production with Lucitone - Dental Tribune US
Precision Trading with Dentsply Sirona Inc. (XRAY) Risk Zones - Stock Traders Daily
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) added to Russell 2000 Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS:XRAY) dropped from Russell Midcap Value Benchmark - marketscreener.com
iCAT and BluePort Legal launch UPC battle against dental tech giant Dentsply - JUVE Patent
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) added to Russell 2000 Value Benchmark - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Value Benchmark - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell 1000 Dynamic Index - marketscreener.com
DENTSPLY SIRONA Inc.(NasdaqGS: XRAY) dropped from Russell Midcap Index - marketscreener.com
Daily Brief Health Care: AxoGen Inc, Dentsply International and more - Smartkarma
DENTSPLY SIRONA, Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh - TradingView
Enterprise value to revenue forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Tranche Update on DENTSPLY SIRONA Inc.'s Equity Buyback Plan announced on March 16, 2005. - marketscreener.com
Enterprise value to revenue forward of DENTSPLY SIRONA, Inc. – FWB:DY2 - TradingView
Gothenburg hosts Implant Solutions World Summit 2026 - Dental Tribune US
Enterprise value to EBIT forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Price to book forward of DENTSPLY SIRONA, Inc. – FWB:DY2 - TradingView
Enterprise value to EBIT forward of DENTSPLY SIRONA, Inc. – FWB:DY2 - TradingView
DENTSPLY SIRONA, Inc. Actuals & Estimates (NASDAQ:XRAY) - TradingView
XRAY Technical Analysis & Stock Price Forecast - Intellectia AI
Price to earnings forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Enterprise value to EBITDA forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
XRAY Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of DENTSPLY SIRONA Inc. – NASDAQ:XRAY - TradingView
Dental Equipment & Technology Stocks Q1 In Review: Dentsply Sirona (NASDAQ:XRAY) Vs Peers - Yahoo Finance
How Investors May Respond To DENTSPLY SIRONA (XRAY) Appointing John C. Fortson As CFO And EVP - Sahm
Dentsply Sirona StockLong-term business model under scrutiny - AD HOC NEWS
DENTSPLY SIRONA (XRAY) Stock Could Be 78% Undervalued After CFO Appointment - Sahm
Thursday insider buys and sells: Directors load up on healthcare By Investing.com - Investing.com Nigeria
Dentsply Sirona director Jonathan Mazelsky buys $101,400 in shares - Investing.com UK
XRAY News | DENTSPLY SIRONA INC (NASDAQ:XRAY) - ChartMill
Dentsply Sirona director Jonathan Mazelsky buys $101,400 in shares By Investing.com - Investing.com Canada
Dentsply Sirona (XRAY) director amends Form 4 to show share purchase - Stock Titan
Dentsply Sirona (XRAY) SVP details stock, RSU, phantom and option holdings - Stock Titan
DENTSPLY SIRONA Inc (XRAY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dentsply Sirona Inc Azioni (XRAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MCKEON BRIAN P | Director |
Jun 12 '26 |
Buy |
10.12 |
10,000 |
101,200 |
10,000 |
| Gladden Brian T | Director |
Jun 15 '26 |
Buy |
10.02 |
9,985 |
100,000 |
61,849 |
| HOLDEN BETSY D | Director |
Jun 11 '26 |
Buy |
9.88 |
10,086 |
99,692 |
87,528 |
| Barber Michael J | Director |
Jun 11 '26 |
Buy |
9.88 |
15,175 |
150,005 |
55,943 |
| LUCIER GREGORY T | Director |
Mar 09 '26 |
Buy |
12.45 |
15,000 |
186,675 |
65,000 |
| Forbes James D | Director |
Mar 09 '26 |
Buy |
12.48 |
5,000 |
62,400 |
10,000 |
| LUCIER GREGORY T | Director |
Mar 02 '26 |
Buy |
14.24 |
27,555 |
392,521 |
27,555 |
| LUCIER GREGORY T | Director |
Mar 03 '26 |
Buy |
14.03 |
22,445 |
314,858 |
50,000 |
1.30%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):